Note- old diseases and conditions continue to return, such

New Post Public Reply Private Reply Replies (2) Message Board
microcaps microcaps #5594
500
Note- old diseases and conditions continue to return, such as tb, measles etc. The bubonic plague itself continues to affect Americans. e.g.,https://www.scientificamerican.com/article/100-years-of-bubonic-plague/
Plus a panoply of new diseases/conditions will continue to grow as per many sources-so whether or not NNLX's N-assay is used for the current pandemic, the N -assay will continue to be useful against a wide range of bacterial and viral conditions in the future,as NNLX has noted, especially in comparison to the more limited diagnosis afforded by the current pcr or pcp tech.

And yes, the govt contractor -whoever they are -who showed an interest in NNLX's N- assay -as per a preliminary agreement- is not likely to disappear in a week or two. I've explained ad nauseum in the past why it takes so long for things to move forward,given the required dd and communication among several disparate specialized groups who do not speak the same language.


almost all drugs have side effects and become toxic at some level of dosage. E.g., I've read that acetaminophen can cause liver failure at just 4000 mg/day (in fact in some cases as low as 2000mg/day i think i've read)=-bottles say do not exceed 4000mg/day or use with certain other drugs or take 3 or more alcoholic drinks/day. Untreated liver failure results in death.

https://www.uspharmacist.com/article/acetamin...ed-to-know

from the cited article: Acetaminophen toxicity is one of the most common causes of both intentional and unintentional poisoning in the U.S. In fact, there has been a steady increase in the incidence of acetaminophen-related toxicity over the past decade.... Acetaminophen-associated overdoses account for approximately 56,000 emergency department visits, 26,000 hospitalizations, and over 450 deaths annually.9

if such a commonly used drug as acetaminophen is so toxic then its odd that a reported side effect in just ONE wrong self diagnosed self treating patient was used in one article https://fortune.com/2020/03/20/malaria-drug-c...dly-china/ to caution against chloroquine treatment for covid 19- such a strange event/article title is more likely part of current widespread political assassination attempts.

the ff was the journal article cited by my post
https://www.sciencedirect.com/science/article...via%3Dihub

https://www.ncbi.nlm.nih.gov/pubmed/32164085
the wiki article https://en.wikipedia.org/wiki/Chloroquine notes that
a further study concluded that hydroxychloroquine was more potent than chloroquine, with a more tolerable safety profile

one article said the older less safe form of chloroquine was widely used by europeans before entering any malaria prone theater and that said europeans continued on a dosage of such for 2 months AFTER exiting malaria prone areas. Obviously- even the older less safe form of the treatment were considered an improvement compared to malaria.

Of course, today safety is emphasized more than decades ago,but in all cases drugs are intended for particular uses under a doctors direction- and are not to be used willy nilly as per a wrong self diagnosis as did the chinese woman who developed arrhythmia- which is contraindicated for chloroquine, just as a long list of drugs are contraindicated for those with heart problems. In most such cases it is the side effect which kills -often in people prone to such a side effect.
In italy i've read that up to 99% of deaths occurred in those with a previous underlying medical condition.
As French and Australian and Chinese work with chloroquine (which was also effective against some previous corona viruses) and its safer derivatives came to light it was naturally jumped on as a possible treatment modality, and it still is, since regulatory approval for all potential vaccines seems to be one year away, according to reports i've read and heard.

So non-scientists, including politicians, will in the current climate of runaway fear be glad to push such a potential treatment.
That is part of their job to calm fears in a fear prone populace.

Meanwhile scientists,who by nature must be more cautious -want to look at the studies first and determine whether other studies or tests are necessary for safety purposes before jumping into the boat. This paradigm should be well known and understood-and remember it was scientists use of chloroquine or its safer derivatives and their scientific statements that such use was highly effective against the virus in their studies/samples that got politicians and others excited,as it should-why -because we cannot idly sit by and wait one year for a vaccine to be approved before we start to combat the virus. That should be obvious.



Nanologix Inc (NNLX) Stock Research Links

NNLX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Hygenco Partners with REC for Major Green Ammonia Initiative

Updated Category News Views 72

Hygenco Partners with REC for Green Ammonia Initiative Hygenco Green Energies Pvt Ltd, recognized for its innovative methods in producing cost-effective green hydrogen, has recently entered into a Memorandum of Understanding (MOU) with REC Limited, previously referred to as the Rural Electrification Corporation Limited. This collaboration is geared towards financing...

Continue Reading
Unilumin's Innovative Leap: AI Services for Diverse Industries

Updated Category News Views 251

Unilumin's Revolutionary Transformation into AI Services Shenzhen, China has become a hub for innovation as Unilumin Group celebrates a significant milestone. Recently, the company hosted a momentous event that marked its transition from a traditional display hardware supplier to an advanced AI intelligent service application provider. AI Forum Celebrating Visionary...

Continue Reading
Asiacell Partners with Google Cloud for AI Tools in Iraq

Updated Category News Views 173

Asiacell Unveils Strategic Collaboration with Google Cloud Asiacell, a notable player in the telecommunications industry, has embarked on an exciting journey by collaborating with Google Cloud. This partnership is set to transform how businesses and educational institutions in Iraq leverage technology by introducing cutting-edge digital tools. Introduction of Google...

Continue Reading
Explore Dwell's Exclusive Home Tours in Los Angeles This Fall

Updated Category News Views 215

Experience Architectural Innovation with Dwell The upcoming event by Dwell invites design enthusiasts to engage with three exceptional residences and the renowned Hollyhock House, designed by architectural legend Frank Lloyd Wright. This unique experience will highlight the creativity and contemporary approach prevalent in modern residential architecture. Exclusive Home...

Continue Reading
Swift Textile Metalizing Marks Ten Years of Supplier Honors

Updated Category News Views 109

Swift Textile Metalizing Marks Ten Years of Supplier Honors STM proudly announces that its Advance Defense Solutions Division has been recognized with Lockheed Martin's elite honors over the past ten years. This includes the prestigious "Elite Supplier", "Star Supplier", and "Ahead of Ready" awards, showcasing a deep commitment to quality in delivery and service....

Continue Reading